NCT05889169View on ClinicalTrials.gov

Stroke-induced Immunodepression in Neurorehabilitation

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

May 30, 2022

Study Completion Date

September 30, 2022

Conditions
StrokeLymphopeniaImmunosuppression
Interventions
OTHER

Neurorehabilitation

Four to eight weeks motor rehabilitation (500 minutes per week across 6 day per week)

Trial Locations (1)

27100

Headache Science & Neurorehabilitation Center, Pavia

All Listed Sponsors
lead

"IRCCS National Neurological Institute C. Mondino Foundation"

OTHER

NCT05889169 - Stroke-induced Immunodepression in Neurorehabilitation | Biotech Hunter | Biotech Hunter